United States: Special Needs Plans: A Minibus Rider

As Part of an ongoing series, we have previously provided details on the structure, funding, and evaluation of the Maternal, Infant, Early Childhood, Home Visiting (MIECHV) program, Medicare therapy caps, and community health center funding. This post marks is the first in an exploratory series illuminating the structure, funding, and outlook of the Special Needs Plans (SNPs). Additionally, drawing on potential riders affected by the current health care minibus, the "minibus" refers to a handful of policy provisions tied together in one piece of legislation. Undoubtedly, this minibus will carry a number of provisions into law. The number of riders who will be on board when the minibus leaves the station remains to be seen. However, as Congress gears up for a mega-package in December – including the debt limit and the budget – there is the potential to incorporate the minibus and/or a health care stabilization package.

Future posts will review additional details of other potential riders on the minibus.


SNPs, which are a subset of Medicare Advantage plans, are expressly designed to target care and limit enrollment to individuals with special needs. SNPs include:

  • Dual-eligible special needs plans (D-SNPs) , designed for individuals dually eligible for Medicare and Medicaid. D-SNP plans provide a coordinated Medicaid and Medicare benefit package that offers more integrated care than regular Medicare Advantage plans or traditional Medicare FFS. D-SNPs contract with the state Medicaid agency to provide Medicaid benefits or arrange for Medicaid benefits to be provided.
  • Chronic condition special needs plans (C-SNPs), limited to individuals with specific severe or disabling chronic conditions.
  • Institutional special needs plans (I-SNPs), restricted to individuals whom, for 90 days or longer, have needed or are expected to need the level of services provided in an institutional setting.

Current SNP authorization provisions are set to expire December 31, 2018. For these programs to continue, Congress will need to extend or permanently authorize the programs.

Released in September 2017, the most recent Comprehensive SNP Report published by the Centers for Medicare & Medicaid Services (CMS), indicates that there are more than 2 million current D-SNP beneficiaries, over 345,000 individuals enrolled in C-SNPs, and approximately 67,000 I-SNP recipients. Additionally, of the 583 SNP plans, D-SNPs constitute approximately 65% of all SNP plans.

Medicare and Medicaid Integration in D-SNPs

D-SNPs are intended to coordinate Medicare and Medicaid services, as well as integrate the financial structure of the Medicare and Medicaid programs. However, studies have shown that some D-SNPs do not clinically or financially integrate Medicaid benefits, and do not cover some or all of Medicaid's LTSS or behavioral health services. Fully Integrated Dual Eligible (FIDE) SNPs were created through the ACA to promote the full integration and coordination of Medicare and Medicare benefits, and financing of services, for dually eligible beneficiaries.

However, to date there are very few FIDE SNPs. In 2013, the Medicare Payment Advisory Commission (MedPAC) recommended to reauthorize only those D-SNP plans that assume clinical and financial responsibility for Medicare and Medicaid benefits, and to allow the authority for all other D-SNPs to expire.

Next Steps for SNPs

Both the Senate and House have indicated movement on SNP reauthorization intentions. On Tuesday, September 26th, the same day the Graham-Cassidy healthcare bill "died", the Senate unanimously passed The Creating High-Quality Results and Outcomes Necessary to Improve Chronic (CHRONIC) Care Act of 2017. This bill would permanently authorize SNPs. Additionally, the bill works to improve Medicare and Medicaid integration among D-SNPs. It includes requirements on coordinating Medicaid's long term services and supports and behavioral health services in D-SNP contracts and thus addresses some of the Medicare-Medicaid integration issues noted above. Further, the bill authorizes the Secretary of HHS to establish procedures to develop a unified Medicare and Medicaid appeals and grievance process for individuals in D-SNPs, which aims to improve the administrative processes between Medicare and Medicaid for dually eligible beneficiaries.

Other provisions of the bill call for improving C-SNPs care management, revising the current chronic care definition, and directing the HHS Secretary, every five years, to revisit the definition of a qualifying chronic condition. The CHRONIC Care Act additionally extends the Independence at Home demonstration program for two years, expands the use of telehealth services, and rescinds funding meant to improve the Medicare fee-for-service program. CBO estimates that the CHRONIC Care Act would reduce direct spending for the Medicare and Medicaid programs by $217 million from 2018-2022. This bill has been referred to the House Ways and Means Committee and Energy and Commerce Committee.

On the House side, the House Ways and Means Committee introduced and approved bill H.R. 3168. As it pertains to SNPs, H.R. 3168 has similar, if not the same, provisions as the CHRONIC Care Act. H.R. 3168 would create a unified Medicare and Medicaid appeals and grievance process for D-SNPs; improve C-SNP care management; revise the definition of chronic care and Medicare-Medicaid integration requirements for D-SNPs; and direct the Secretary to revisit the definition of a qualifying chronic condition every five years. However, while the Senate bill permanently authorizes SNPs, the House bill would reauthorize D-SNPs and C-SNPs for only 5 years and only permanently reauthorize I-SNPs. CBO estimates H.R. 3168 would increase direct spending by $119 million between 2017 and 2027.

Also of note, the House Energy and Commerce Health Subcommittee unanimously advanced seven Medicare-related bills to the full Committee on September 13th. These bills include many of the same provisions that are in the CHRONIC Care Act, but did not include a bill focused on SNP reauthorization. So far the E&C Committee held a hearing on SNPs in July and published a discussion draft on SNP reauthorization.

In short, SNP reauthorization contains an array of moving parts. We will be watching how SNP reauthorization interacts with the rest of the health care minibus, the health care stabilization package, and a large mega-deal encompassing the budget and debt limit.

*Nicole Meyerson of MLS Strategies also contributed to this post.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

Rodney L. Whitlock
Similar Articles
Relevancy Powered by MondaqAI
Drinker Biddle & Reath LLP
In association with
Related Topics
Similar Articles
Relevancy Powered by MondaqAI
Drinker Biddle & Reath LLP
Related Articles
Related Video
Up-coming Events Search
Font Size:
Mondaq on Twitter
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
Email Address
Company Name
Confirm Password
Mondaq Topics -- Select your Interests
 Law Performance
 Law Practice
 Media & IT
 Real Estate
 Wealth Mgt
Asia Pacific
European Union
Latin America
Middle East
United States
Worldwide Updates
Registration (you must scroll down to set your data preferences)

Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice):

  • To allow you to personalize the Mondaq websites you are visiting to show content ("Content") relevant to your interests.
  • To enable features such as password reminder, news alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our content providers ("Contributors") who contribute Content for free for your use.

Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below.

Mondaq has a "free to view" business model. Our services are paid for by Contributors in exchange for Mondaq providing them with access to information about who accesses their content. Once personal data is transferred to our Contributors they become a data controller of this personal data. They use it to measure the response that their articles are receiving, as a form of market research. They may also use it to provide Mondaq users with information about their products and services.

Details of each Contributor to which your personal data will be transferred is clearly stated within the Content that you access. For full details of how this Contributor will use your personal data, you should review the Contributor’s own Privacy Notice.

Please indicate your preference below:

Yes, I am happy to support Mondaq in maintaining its free to view business model by agreeing to allow Mondaq to share my personal data with Contributors whose Content I access
No, I do not want Mondaq to share my personal data with Contributors

Also please let us know whether you are happy to receive communications promoting products and services offered by Mondaq:

Yes, I am happy to received promotional communications from Mondaq
No, please do not send me promotional communications from Mondaq
Terms & Conditions

Mondaq.com (the Website) is owned and managed by Mondaq Ltd (Mondaq). Mondaq grants you a non-exclusive, revocable licence to access the Website and associated services, such as the Mondaq News Alerts (Services), subject to and in consideration of your compliance with the following terms and conditions of use (Terms). Your use of the Website and/or Services constitutes your agreement to the Terms. Mondaq may terminate your use of the Website and Services if you are in breach of these Terms or if Mondaq decides to terminate the licence granted hereunder for any reason whatsoever.

Use of www.mondaq.com

To Use Mondaq.com you must be: eighteen (18) years old or over; legally capable of entering into binding contracts; and not in any way prohibited by the applicable law to enter into these Terms in the jurisdiction which you are currently located.

You may use the Website as an unregistered user, however, you are required to register as a user if you wish to read the full text of the Content or to receive the Services.

You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these Terms or with the prior written consent of Mondaq. You may not use electronic or other means to extract details or information from the Content. Nor shall you extract information about users or Contributors in order to offer them any services or products.

In your use of the Website and/or Services you shall: comply with all applicable laws, regulations, directives and legislations which apply to your Use of the Website and/or Services in whatever country you are physically located including without limitation any and all consumer law, export control laws and regulations; provide to us true, correct and accurate information and promptly inform us in the event that any information that you have provided to us changes or becomes inaccurate; notify Mondaq immediately of any circumstances where you have reason to believe that any Intellectual Property Rights or any other rights of any third party may have been infringed; co-operate with reasonable security or other checks or requests for information made by Mondaq from time to time; and at all times be fully liable for the breach of any of these Terms by a third party using your login details to access the Website and/or Services

however, you shall not: do anything likely to impair, interfere with or damage or cause harm or distress to any persons, or the network; do anything that will infringe any Intellectual Property Rights or other rights of Mondaq or any third party; or use the Website, Services and/or Content otherwise than in accordance with these Terms; use any trade marks or service marks of Mondaq or the Contributors, or do anything which may be seen to take unfair advantage of the reputation and goodwill of Mondaq or the Contributors, or the Website, Services and/or Content.

Mondaq reserves the right, in its sole discretion, to take any action that it deems necessary and appropriate in the event it considers that there is a breach or threatened breach of the Terms.

Mondaq’s Rights and Obligations

Unless otherwise expressly set out to the contrary, nothing in these Terms shall serve to transfer from Mondaq to you, any Intellectual Property Rights owned by and/or licensed to Mondaq and all rights, title and interest in and to such Intellectual Property Rights will remain exclusively with Mondaq and/or its licensors.

Mondaq shall use its reasonable endeavours to make the Website and Services available to you at all times, but we cannot guarantee an uninterrupted and fault free service.

Mondaq reserves the right to make changes to the services and/or the Website or part thereof, from time to time, and we may add, remove, modify and/or vary any elements of features and functionalities of the Website or the services.

Mondaq also reserves the right from time to time to monitor your Use of the Website and/or services.


The Content is general information only. It is not intended to constitute legal advice or seek to be the complete and comprehensive statement of the law, nor is it intended to address your specific requirements or provide advice on which reliance should be placed. Mondaq and/or its Contributors and other suppliers make no representations about the suitability of the information contained in the Content for any purpose. All Content provided "as is" without warranty of any kind. Mondaq and/or its Contributors and other suppliers hereby exclude and disclaim all representations, warranties or guarantees with regard to the Content, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. To the maximum extent permitted by law, Mondaq expressly excludes all representations, warranties, obligations, and liabilities arising out of or in connection with all Content. In no event shall Mondaq and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use of the Content or performance of Mondaq’s Services.


Mondaq may alter or amend these Terms by amending them on the Website. By continuing to Use the Services and/or the Website after such amendment, you will be deemed to have accepted any amendment to these Terms.

These Terms shall be governed by and construed in accordance with the laws of England and Wales and you irrevocably submit to the exclusive jurisdiction of the courts of England and Wales to settle any dispute which may arise out of or in connection with these Terms. If you live outside the United Kingdom, English law shall apply only to the extent that English law shall not deprive you of any legal protection accorded in accordance with the law of the place where you are habitually resident ("Local Law"). In the event English law deprives you of any legal protection which is accorded to you under Local Law, then these terms shall be governed by Local Law and any dispute or claim arising out of or in connection with these Terms shall be subject to the non-exclusive jurisdiction of the courts where you are habitually resident.

You may print and keep a copy of these Terms, which form the entire agreement between you and Mondaq and supersede any other communications or advertising in respect of the Service and/or the Website.

No delay in exercising or non-exercise by you and/or Mondaq of any of its rights under or in connection with these Terms shall operate as a waiver or release of each of your or Mondaq’s right. Rather, any such waiver or release must be specifically granted in writing signed by the party granting it.

If any part of these Terms is held unenforceable, that part shall be enforced to the maximum extent permissible so as to give effect to the intent of the parties, and the Terms shall continue in full force and effect.

Mondaq shall not incur any liability to you on account of any loss or damage resulting from any delay or failure to perform all or any part of these Terms if such delay or failure is caused, in whole or in part, by events, occurrences, or causes beyond the control of Mondaq. Such events, occurrences or causes will include, without limitation, acts of God, strikes, lockouts, server and network failure, riots, acts of war, earthquakes, fire and explosions.

By clicking Register you state you have read and agree to our Terms and Conditions